JP2022529529A5 - - Google Patents
Info
- Publication number
- JP2022529529A5 JP2022529529A5 JP2021563196A JP2021563196A JP2022529529A5 JP 2022529529 A5 JP2022529529 A5 JP 2022529529A5 JP 2021563196 A JP2021563196 A JP 2021563196A JP 2021563196 A JP2021563196 A JP 2021563196A JP 2022529529 A5 JP2022529529 A5 JP 2022529529A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- seq
- tau
- liposomes
- administering
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962837987P | 2019-04-24 | 2019-04-24 | |
| US62/837,987 | 2019-04-24 | ||
| PCT/US2020/029477 WO2020219646A1 (en) | 2019-04-24 | 2020-04-23 | Heterologous administration of tau vaccines |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022529529A JP2022529529A (ja) | 2022-06-22 |
| JP2022529529A5 true JP2022529529A5 (cg-RX-API-DMAC7.html) | 2023-09-04 |
| JP7617852B2 JP7617852B2 (ja) | 2025-01-20 |
Family
ID=72921263
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021563196A Active JP7617852B2 (ja) | 2019-04-24 | 2020-04-23 | タウワクチンの異種投与 |
Country Status (18)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| TW202333768A (zh) | 2017-10-25 | 2023-09-01 | 美商健生醫藥公司 | Tau胜肽之組成物及其用途 |
| KR20210124308A (ko) | 2019-01-30 | 2021-10-14 | 트루바인딩 아이엔씨. | 항-gal3 항체 및 이의 용도 |
| SG11202108312PA (en) | 2019-02-08 | 2021-08-30 | Ac Immune Sa | Method of safe administration of phosphorylated tau peptide vaccine |
| AU2021276616A1 (en) * | 2020-05-20 | 2023-01-05 | Bicycletx Limited | Bicyclic peptide ligands specific for Nectin-4 and uses thereof |
| MX2022014786A (es) | 2020-05-26 | 2023-01-16 | Truebinding Inc | Metodos para tratar enfermedades inflamatorias mediante el bloqueo de galectina-3. |
| KR20240042508A (ko) * | 2021-08-12 | 2024-04-02 | 얀센 파마슈티칼즈, 인코포레이티드 | 지속적인 면역 반응을 유도하기 위한 인산화 타우 펩티드를 함유하는 리포솜 |
| EP4408864A4 (en) * | 2021-09-29 | 2025-09-03 | Janssen Pharmaceuticals Inc | METHOD FOR SAFE ADMINISTRATION OF A TAU PHOSPHOPEPTIDE CONJUGATE |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5811310A (en) | 1986-09-30 | 1998-09-22 | Albert Einstein College Of Medicine Of Yeshiva Univ. | The Alz-50 monoclonal antibody and diagnostic assay for alzheimer's disease |
| WO1990014837A1 (en) | 1989-05-25 | 1990-12-13 | Chiron Corporation | Adjuvant formulation comprising a submicron oil droplet emulsion |
| US7408027B1 (en) | 1991-12-06 | 2008-08-05 | Max-Planck-Gesellschaft Zur Forderung Der Wissenchaften | Tools for the diagnosis and treatment of Alzheimer's disease |
| AU690092B2 (en) | 1992-12-14 | 1998-04-23 | N.V. Innogenetics S.A. | Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications |
| US7427392B1 (en) | 1994-11-14 | 2008-09-23 | Elan Pharmaceuticals, Inc. | Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau |
| WO1997034145A1 (fr) | 1996-03-13 | 1997-09-18 | Mitsubishi Chemical Corporation | Anticorps a proteine tau antiphosphorylee et procede de detection de la maladie d'alzheimer l'utilisant |
| WO1998022120A1 (en) | 1996-11-19 | 1998-05-28 | The Wistar Institute Of Anatomy & Biology | Diagnostic and therapeutic reagents for alzheimer's disease |
| AU2001273361A1 (en) | 2000-07-11 | 2002-01-21 | Molecular Geriatrics Corporation | Reagents and methods for identification of binding agents |
| AU2003203079B9 (en) | 2002-02-04 | 2009-01-15 | Oncothyreon Inc. | Immunostimulatory, covalently lipidated oligonucleotides |
| KR100994748B1 (ko) | 2002-04-19 | 2010-11-17 | 더 가버닝 카운실 오브 더 유니버시티 오브 토론토 | 알쯔하이머병의 치료를 위한 면역학적 방법 및 조성물 |
| US8663650B2 (en) | 2003-02-21 | 2014-03-04 | Ac Immune Sa | Methods and compositions comprising supramolecular constructs |
| US20050261475A1 (en) | 2004-02-13 | 2005-11-24 | Harvard Medical School | Solid-phase capture-release-tag methods for phosphoproteomic analyses |
| US7238788B2 (en) | 2004-02-18 | 2007-07-03 | University Of Iowa Foundation | Antibodies to phosphorylated tau, methods of making and methods of use |
| WO2007068105A1 (en) | 2005-12-12 | 2007-06-21 | Robarts Research Institute | Method of diagnosing amyotrophic lateral sclerosis |
| CA2633399C (en) | 2005-12-12 | 2016-01-26 | Ac Immune S.A. | Therapeutic vaccine |
| US8012936B2 (en) | 2006-03-29 | 2011-09-06 | New York University | Tau fragments for immunotherapy |
| US20080220449A1 (en) | 2007-02-08 | 2008-09-11 | Oligomerix, Inc. | Biomarkers and assays for Alzheimer's disease |
| KR20100115340A (ko) | 2007-10-19 | 2010-10-27 | 이무나스 파마 가부시키가이샤 | Aβ 올리고머에 특이적으로 결합하는 항체 및 그의 이용 |
| MX2011009654A (es) | 2009-03-18 | 2011-10-12 | Ac Immune Sa | Metodo para uso terapeutico. |
| UA107571C2 (xx) | 2009-04-03 | 2015-01-26 | Фармацевтична композиція | |
| EP4218794A3 (en) | 2009-06-10 | 2023-09-13 | New York University | Immunological targeting of pathological tau proteins |
| CN102596236B (zh) | 2009-07-30 | 2015-06-24 | 辉瑞疫苗有限责任公司 | 抗原性Tau肽及其用途 |
| WO2012020124A1 (en) | 2010-08-12 | 2012-02-16 | Ac Immune S.A. | Vaccine engineering |
| EP2632434B1 (en) * | 2010-10-26 | 2025-08-20 | AC Immune S.A. | Liposome-based construct comprising a peptide modified through hydrophobic moieties |
| AU2012272815B2 (en) * | 2011-06-22 | 2017-09-07 | The General Hospital Corporation | Treatment of proteinopathies |
| EP3275461A1 (en) * | 2011-09-19 | 2018-01-31 | Axon Neuroscience SE | Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease field |
| CN105939722A (zh) * | 2014-02-14 | 2016-09-14 | 伊皮埃里安股份有限公司 | Tau肽,抗Tau抗体,及其使用方法 |
| CA2952741A1 (en) | 2014-06-26 | 2015-12-30 | Janssen Vaccines & Prevention B.V. | Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau |
| NZ775762A (en) | 2015-06-05 | 2025-02-28 | Genentech Inc | Anti-tau antibodies and methods of use |
| EP3551220B1 (en) | 2016-12-07 | 2025-01-29 | Genentech, Inc. | Anti-tau antibodies and methods of use |
| TW202333768A (zh) | 2017-10-25 | 2023-09-01 | 美商健生醫藥公司 | Tau胜肽之組成物及其用途 |
| CN111587123A (zh) * | 2017-11-09 | 2020-08-25 | 品通治疗有限公司 | 用于生成和使用人源化构象特异性磷酸化的τ抗体的方法和组合物 |
-
2020
- 2020-04-23 MX MX2021012994A patent/MX2021012994A/es unknown
- 2020-04-23 BR BR112021021213A patent/BR112021021213A2/pt not_active IP Right Cessation
- 2020-04-23 CN CN202080046201.9A patent/CN114173812B/zh active Active
- 2020-04-23 PH PH1/2021/552683A patent/PH12021552683A1/en unknown
- 2020-04-23 EA EA202192891A patent/EA202192891A1/ru unknown
- 2020-04-23 KR KR1020217038109A patent/KR20220005033A/ko not_active Ceased
- 2020-04-23 AU AU2020262899A patent/AU2020262899A1/en not_active Abandoned
- 2020-04-23 JO JOP/2021/0284A patent/JOP20210284A1/ar unknown
- 2020-04-23 TW TW109113654A patent/TW202110478A/zh unknown
- 2020-04-23 EP EP20796144.2A patent/EP3965817A4/en active Pending
- 2020-04-23 SG SG11202111770RA patent/SG11202111770RA/en unknown
- 2020-04-23 MA MA055902A patent/MA55902A/fr unknown
- 2020-04-23 CA CA3137884A patent/CA3137884A1/en active Pending
- 2020-04-23 JP JP2021563196A patent/JP7617852B2/ja active Active
- 2020-04-23 US US16/856,400 patent/US11591377B2/en active Active
- 2020-04-23 WO PCT/US2020/029477 patent/WO2020219646A1/en not_active Ceased
-
2021
- 2021-10-21 IL IL287486A patent/IL287486A/en unknown
- 2021-10-22 ZA ZA2021/08168A patent/ZA202108168B/en unknown
-
2023
- 2023-02-20 US US18/171,498 patent/US20230257433A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250326806A1 (en) | Compositions of Phosphorylated Tau Peptides and Uses Thereof | |
| JP2021501147A5 (cg-RX-API-DMAC7.html) | ||
| US11591377B2 (en) | Heterologous administration of tau vaccines | |
| KR20200143422A (ko) | 항-aveta 치료적 백신 | |
| US20250152684A1 (en) | Anti-Alpha-Synuclein Therapeutic Vaccines | |
| JP2023536497A (ja) | 免疫原性化合物 | |
| JP2022533422A5 (cg-RX-API-DMAC7.html) | ||
| JP2025506472A5 (cg-RX-API-DMAC7.html) | ||
| KR20250135293A (ko) | 리포좀 구조체 | |
| CN118660717A (zh) | 抗α-突触核蛋白的治疗性疫苗 | |
| HK40105209A (en) | Compositions of phosphorylated tau peptides and uses thereof | |
| JP2024538615A5 (cg-RX-API-DMAC7.html) | ||
| EA051687B1 (ru) | Терапевтические вакцины против альфа-синуклеина | |
| HK40039870B (en) | Compositions of phosphorylated tau peptides and uses thereof | |
| HK40039870A (en) | Compositions of phosphorylated tau peptides and uses thereof |